Who can apply?
The webinar is open for members and non-members and all age groups. Participants need to register with the ESPGHAN Office. The participation is free of charge. To register, please send an email to office@espghan.org
Registrations are on a first-com, first-served basis so we recommend to register early. We reserve the right to close registration if capacity is reached before the below mentioned deadlines.
Date 29th June 2023 19:00-20:00 CET
Registration deadline: 28th June 2023
Speakers Bahee Van de Bor - Specialist Paediatric Dietitian
Bahee Van de Bor is an award-winning UK registered paediatric dietitian with 18 years of clinical experience, including 12 years at Great Ormond Street Children's Hospital. She now specialises in paediatric Irritable Bowel Syndrome (IBS) and is certified by Monash University to teach the low FODMAPs diet. Bahee has published a few articles on topics in paediatric nutrition and regularly presents webinars and speaks at national and international conferences. She is also a media spokesperson for the British Dietetic Association (BDA) and serves as the vice chair of the BDA Paediatric Committee.
Description
This webinar will give an overview of the nutritional management of IBS, including the low FODMAP diet, in paediatric patients, as well as an up-to-date overview of the research in the area. The presenter Bahee van der Bor is a Specialist Paediatric Dietitian, previously at Great Ormond Street, but now with a private practise in the UK. She is a media spokesperson for the British Dietetic Association (BDA) and serves as the vice chair of the BDA Paediatric Committee. This webinar is organized by the ESPGHAN AHP Committee
Date: October 31, 2023. 17:00 – 18:00 CET
Registration deadline: October 29, 2023
Speakers
Valerie McLin - Geneva, Switzerland
Emmanuel Gonzales - Paris, France
ICU: Akash Deep
Surgery: Barbara Wildhaber
Anesthesia: Matthew Pearsall
Ethics: Joe Brierley
Description:
End stage liver disease and acute liver failure are systemic, often fatal conditions. In addition, patients of all ages with these conditions may also present with several co-morbidities. Extracorporeal life support is increasingly performant. This webinar aims to explore when, in eligible LT candidates, life-saving efforts are no longer in the best interest of the patient or family. We will explore 4 different points of view: surgery, intensive care, anesthesia, and ethics.
This webinar is organized by the ESPGHAN Hepatology Committee
Date: November 23, 2021. 17:00 - 18:00 CET
Registration Deadline; November 22, 2021
Topic: Hepatolgy
Speakers:
Emer Fitzpatrick
Consultant Paediatric Hepatologist/Gastroenterologist
CHI Crumlin, Dublin, Ireland
Vandana Jain
Consultant Paediatric Hepatologist
Kings College London, London, United Kingdom
Marianne Samyn
Consultant Paediatric Hepatologist
Kings College London, London, United Kingdom
Description: The long-term outcomes of children with biliary atresia, the most common indication for liver transplantation in childhood, will be explored in this webinar. One in five of those with biliary atresia will reach the age of 20 with their native liver, but poor psychosocial outcome, educational attainment and employment prospects result in impaired quality of life. Complications such as cholangitis and portal hypertension may only come to light during adolescence and need a specialised approach. The timing of liver transplantation in adolescence and young people is an evolving focus of interest. This webinar will discuss medical, surgical, psychosocial issues in adolescents and young people with BA and focus on our role in optimising their long-term outcomes.
Organisers: Emer Fitzpatrick and Marianne Samyn (ESPGHAN Hepatology Committee)
This webinar is part of a webinar series by the ESPGHAN Hepatology Committee
Date: October 27, 2021. 17:00 - 18:00 CEST
Registration Deadline; October 25, 2021
Topic: Hepatology
Speakers:
Girish Gupte
Consultant Paediatric Hepatologists, Birmingham Women's and Children's Hospital, Birmingham, UK
Chaya Kelgeri
Consultant Paediatric Hepatologists, Birmingham Women's and Children's Hospital, Birmingham, UK
Description:
Chronic liver disease is a continuum process leading to end stage liver disease and ultimately needing liver transplantation. With advances made in diagnosis and imaging, more and more children with chronic liver disease are diagnosed worldwide. Paediatricians, paediatric gastroenterologist and hepatologists need to recognise that appropriate management of the chronic liver disease with timely treatment and interventions can halt the progression of liver disease and delay/avoid liver transplantation. Starting from the pathophysiology of chronic liver disease, this webinar will illustrate the nuances in management of chronic liver disease, portal hypertension, ascites and discuss timing of referral for liver transplantation with case-based discussions.
Organisers: Girish Gupte (ESPGHAN Hepatology Committee)
This webinar is part of a webinar series by the ESPGHAN Hepatology Committee
Date: September 30, 2021. 17:00 - 18:00 CEST
Registration Deadline; September 28
Topic: Hepatolgy
Speakers:
Norman Junge
Division for Peadiatric Gastroenterology and Hepatology, Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany
Hendrik Rosewich
Department of Pediatrics and Adolescent Medicine, Division of Pediatric Neurology, University Medical Center Göttingen, Georg August University, Göttingen, Germany
Description:
Neonatal Cholestasis is a rare condition and includes many differential diagnoses of which biliary atresia is the most common one. Over time, advances in diagnostics including genetics have led to the diagnosis of cases of neonatal cholestasis initially labelled as idiopathic however, the diagnostic work up and management of these rarer conditions is often challenging. In addition, they often involve other organ systems, in particular in neuro-metabolic diseases. Furthermore, it is important to exclude non-progressive and self-limiting diseases early to avoid unnecessary invasive diagnostic procedures. The Webinar will address three clinical cases with neonatal cholestasis caused by very rare metabolic/genetic diseases and aims to give an insight in these diseases including the differential work up for neonatal cholestasis.
Organisers: Norman Junge (ESPGHAN Hepatology Committee)
This webinar is part of a webinar series by the ESPGHAN Hepatology Committee
Date: June 23, 2021. 18:00 - 19:00 CET
Registration Deadline; June 12
Topic: Gastroenterology
Speaker: Elena Cernat (Leeds Children Hosiptal, UK)
Date: May 05, 2021. 17:30 - 18:30 CET
Registration Deadline; May 02
Topic: Hepatology
Speakers:
Valerie McLin (University Hospital Geneva, CH)
Stéphanie Franchi Abella (AP-HP Paris, FR)
Moderator:
Emmanuel Gonzales (AP-HP Paris, FR)
Date: September 14, 2022. 17:00 - 18:00 CEST
Registration Deadline: September 13
Speaker: Aglaia Zellos (GR)
Case presenter : Eleanna Stasinou (GR)
This webinar is part of the 2022 Webinar Series of the ESPGHAN Hepatology Committee.
Despcription
Acute liver Failure is a rare condition in children, characterized by massive loss of hepatic parenchyma secondary to liver injury, and is associated with significant morbidity and mortality. Initial care is challenging, mainly supportive and requires numerous clinical investigations to establish a diagnosis, while most children may remain undiagnosed. Establishment of a correct diagnosis is key for survival, especially in neonates and infants with an undelying metabolic defect. Therefore, acute liver failure requires prompt diagnosis and referral to a tertiary center were specialized tests can be performed. Liver transplantation is frequently required and timely implementation has improved survival.
This webinar will start with a case presentation of a child admitted in acute liver failure presenting the final diagnosis, clinical implications and treatment options. The diagnosis, initial management options and medical and surgical treatment according to age and disease will be presented. The need for individualized approach and indications and contraindications for liver transplantation will be discussed, focusing in the role of optimizing survival and long-term outcomes
Date: September 22, 2022. 17:00 - 18:00 CEST
Registration Deadline: September 20
Speakers:
Ketil Stordal, NO // Norwegian Institute of Public Health, Oslo; Ostfold Hospital Trust
Margreet Wessels, NL // Department of Pediatrics, Rijnstate Hospital, Arnhem
This webinar is part of the 2022 Webinar Series of the ESPGHAN GI Committee.
Despcription
New ESPGAHN Coeliac Disease 2012 and 2020 diagnostic criteria have supposed a true revolution in the field, the ultimate aim of the proposed criteria being to easy the diagnosis and to avoid unwarranted biopsies while establishing a firm diagnosis.
However, coeliac disease diagnosis may be a real challenge in cases not completely fulfilling these ESPGHAN diagnostic criteria. In patients with low positive serology, mild histological lesions, not valid biopsy simples, or associated disease sometimes it may be difficult to confirm a diagnosis straightaway. Conversely delaying the diagnosis and thus the start of the gluten free diet conveys a real risk of clinical deterioration and/or development of co-morbidities specially autoimmune diseases, osteopenia etc… . On the other hand, overdiagnosis may result in unnecessary dietary restrictions and negative impact on quality of life of patients as well as their family.
This webinar will focus on 2 of these problematic cases and discuss in detail the diagnostic process and the final diagnosis.
Date: October 26, 2022. 17:00 - 18:00 CEST
Registration Deadline: October 24
Speaker: Emanuele Nicastro (IT), Hubert van der Doef (NL)
This webinar is part of the 2022 Webinar Series of the ESPGHAN Hepatology Committee.
Description
Epstein Barr Virus (EBV) and Cytomegalovirus (EBV) infections represent a challenge in the care of liver transplanted children.
Join this webinar to discuss current preventative strategies, unmet needs in the field, and possible development of individualized and precision medicine protocols."
Date: November 24, 2022. 17:00 - 18:00 CEST
Registration Deadline: November 22
Speakers:
Esther Donat Aliaga, ES
La Fee Hospital & Coeliac DIsease Research Unit, Valencia
Caroline R. Meijer-Boekel, NL
Willem-Alexander Kinderziekenhuis. Leids Universitaire Medisch Centerum, Leiden
This webinar is part of the 2022 Webinar Series of the ESPGHAN GI Committee.
Despcription
New ESPGHAN Coeliac Disease 2012 and 2020 diagnostic criteria have supposed a true revolution in the field, the ultimate aim of the proposed criteria being to easy the diagnosis and to avoid unwarranted biopsies while establishing a firm diagnosis.
However, coeliac disease diagnosis may be a real challenge in cases not completely fulfilling the ESPGHAN diagnostic criteria. In patients with low positive serology, mild histological lesions, not valid biopsy simples, or associated disease sometimes it may be difficult to confirm a diagnosis straightaway. Conversely delaying the diagnosis and thus the start of the gluten free diet conveys a real risk of clinical deterioration and/or development of co-morbidities specially autoimmune diseases, osteopenia etc… . On the other hand, overdiagnosis may result in unnecessary dietary restrictions and negative impact on quality of life of patients as well as their family. Thus the need for a consistent diagnosis avoiding under- as well as over diagnosis.
This webinar will analyse in detail 2 of these problematic cases focusing on the specific diagnostic process and rationalizing the final diagnosis